Kyung Dong Pharmaceutical Company Ltd - Earning & Dividend Analysis Snapshot

This detailed Report provides an Earnings and Dividends history for Kyung Dong Pharmaceutical Company Ltd. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.

Kyung Dong Pharmaceutical Company Ltd. The Company's principal activities are manufacturing and selling of pharmaceutical products for multiple therapeutic fields. The Company's two main product groups include finished compounds, including acetaminophen, roxithromycin, acyclovir, ofloxacin, dihydroergocristine methanesulfonate, metformin, levosulpiride, dihydroxyaluminum allantoinate, domperidone maleate, ambroxol and other products, and raw bulk materials, comprised of difemerine hydrochloride, tiropramide hydrochloride, cilostazol, aceclofenac, levofloxacin, nizatidine and rebamipide. In addition, the Company is engaged in the sale of animal drugs and sports related products, among others. Kyungdong Pharmaceutical's products are exported to international customers in Brazil, Cambodia, Chile, Colombia, Costa Rica, India, Japan, Jordan, Pakistan, the Republic of Yemen, Spain, Sudan, Syria and Vietnam.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report